Treatment of Polycystic Ovarian Syndrome in Adults with BMI ≥ 25 kg/m²

Management of polycystic ovarian syndrome (PCOS) shifts meaningfully when the patient is an adult with a body mass index of 25 kg/m² or greater. This protocol is designed for exactly that clinical picture.

Clinical Scenario

Adult patient with a BMI of 25 kg/m² or greater. The presence of elevated BMI alongside PCOS is the defining feature of this protocol and is central to how treatment options are selected and sequenced.

Treatment Approach

In this scenario, the protocol considers a surgical metabolic intervention as part of the management pathway. The full decision criteria, patient eligibility details, and clinical algorithm are available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

Metformin alone should be considered in adults with PCOS and a BMI ≥ 25 kg/m² for anthropometric, and metabolic outcomes including insulin resistance, glucose, and lipid profiles.
Bariatric/ metabolic surgery could be considered to improve weight loss, hypertension, diabetes (prevention and treatment), hirsutism, irregular menstrual cycles, ovulation, and pregnancy rates in women with PCOS.

DOI: 10.1016/j.fertnstert.2023.07.025

View source ↗